Globant’s Q4 Earnings Beat, 2024 Outlook Disappointsby Mark Eisenberg 16.02.2024Globant's Q4 earnings exceed expectations, but falls short on guidance for Q1 and 2024. Cautious market sentiment affects share price. ...
Cellebrite Stock Upgraded by BofA: Buy Now!by Mark Eisenberg 16.02.2024Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
Wyndham Hotels & Resorts: Record Year Successby Mark Eisenberg 16.02.2024Wyndham Hotels & Resorts had a remarkable year in 2023, with impressive performance across various metrics. The company achieved record-breaking ...
Arch Capital Surpasses Expectations: Strategic Gains Resilienceby Terry Bingman 15.02.2024Arch Capital Group has surpassed earnings expectations with strong underwriting and investment gains, showcasing resilience in the insurance sector.
Goldman Sachs Cuts Avis Budget Target: Buying Opportunity?by Mark Eisenberg 14.02.2024Goldman Sachs cuts Avis Budget stock price target as concerns over vehicle depreciation weigh. Lower earnings forecasts and halted stock ...
PepsiCo’s New Forecast: A Refreshing Buy Opportunity?by Mark Eisenberg 12.02.2024PepsiCo lowers organic sales growth forecast, but Citi upgrades stock rating and raises price target due to positive market expectations.